You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VEGF-D

Showing 1 - 25 of 8,528
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

Recruiting
  • Refractory Angina Pectoris
  • +2 more
  • Copenhagen, Denmark
  • +1 more
Oct 19, 2022

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2022

Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

Not yet recruiting
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2023

Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Resectable Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +2 more
  • Houston, Texas
  • +1 more
Oct 12, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Phoenix, Arizona
  • +2 more
Jun 27, 2022

Cancer Patients Treated With Anti-VEGF-Related Therapies

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2021

Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)

Recruiting
  • Liver Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2022

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 13, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

Recruiting
  • Peritoneal Malignant Mesothelioma
  • Atezolizumab
  • +8 more
  • Phoenix, Arizona
  • +25 more
Feb 2, 2023

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Automated Optical Coherence Tomography Image Enrichment With

Active, not recruiting
  • Neovascular Age-Related Macular Degeneration
  • Hamilton, Ontario, Canada
  • +16 more
Aug 8, 2022

Modification of Retinal Nerve Fiber Layer in Patients Treated

Completed
  • Retinal Neovascularization
  • Gonioscopy
  • Lyon, France
  • +2 more
Aug 2, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)

Completed
Has Results
  • Adult Giant Cell Glioblastoma
  • +3 more
  • bevacizumab
  • radiation therapy
  • Birmingham, Alabama
  • +30 more
Dec 27, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

Completed
  • Cervical Adenocarcinoma
  • +6 more
  • Los Angeles, California
  • +21 more
Apr 20, 2021

Ampulla of Vater Adenocarcinoma, Small Intestinal Adenocarcinoma, Stage III Ampulla of Vater Cancer AJCC v8 Trial in Houston

Completed
Has Results
  • Ampulla of Vater Adenocarcinoma
  • +9 more
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 1, 2020

Brain Stem Glioma, Cerebral Astrocytoma, Childhood Cerebellar Anaplastic Astrocytoma Trial in Canada, United States

Active, not recruiting
Has Results
  • Brain Stem Glioma
  • +4 more
  • Bevacizumab
  • +2 more
  • Birmingham, Alabama
  • +136 more
Oct 15, 2022

Pathogenesis and Severity of COVID-19 Disease

Recruiting
  • COVID-19 Disease
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Nov 8, 2022

    Circulating Angiogenic Factors for Second-line Paclitaxel and

    Recruiting
    • Gastric Cancer Stage IV
      • Pisa, Italy
        University of Pisa
      Mar 28, 2022

      Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Houston (biological,

      Unknown status
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • Bevacizumab
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 19, 2020